Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. 1992

G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
Department of Neurology, Yale University School of Medicine, New Haven, CT 06510.

OBJECTIVE Proton magnetic resonance spectroscopy can measure in vivo brain lactate and other metabolites noninvasively. We measured the biochemical changes accompanying stroke in 16 human subjects with cortical or deep cerebral infarcts within the first 3 weeks after symptom onset, and performed follow-up studies on six. METHODS One-dimensional proton spectroscopic imaging encompassing the infarct region was performed with a 2.1-T whole-body magnet using the stimulated echo pulse sequence and an echo time of 270 msec. RESULTS All but one of the cortical stroke patients had increased lactate within or near the infarct. Persistently elevated cerebral lactate was documented in five of six cases studied serially as long as 251 days after infarction. N-acetylaspartate levels were decreased in most cortical strokes. Elevated lactate, accompanied by minimal reduction in N-acetylaspartate, was recorded in two of four patients in the first week following a small subcortical infarct. CONCLUSIONS Long-term elevation of lactate commonly occurs after stroke. This lactate may arise from ongoing ischemia or infiltrating leukocytes, or it may be a residual of the lactate formed during the initial insult. The ability to observe stroke-elevated lactate pools at any time after lesion onset provides an approach to distinguishing among these possibilities in the future.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008744 Methylamines Derivatives of methylamine (the structural formula CH3NH2).
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001224 Aspartic Acid One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. (+-)-Aspartic Acid,(R,S)-Aspartic Acid,Ammonium Aspartate,Aspartate,Aspartate Magnesium Hydrochloride,Aspartic Acid, Ammonium Salt,Aspartic Acid, Calcium Salt,Aspartic Acid, Dipotassium Salt,Aspartic Acid, Disodium Salt,Aspartic Acid, Hydrobromide,Aspartic Acid, Hydrochloride,Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate,Aspartic Acid, Magnesium (2:1) Salt,Aspartic Acid, Magnesium-Potassium (2:1:2) Salt,Aspartic Acid, Monopotassium Salt,Aspartic Acid, Monosodium Salt,Aspartic Acid, Potassium Salt,Aspartic Acid, Sodium Salt,Calcium Aspartate,Dipotassium Aspartate,Disodium Aspartate,L-Aspartate,L-Aspartic Acid,Magnesiocard,Magnesium Aspartate,Mg-5-Longoral,Monopotassium Aspartate,Monosodium Aspartate,Potassium Aspartate,Sodium Aspartate,Aspartate, Ammonium,Aspartate, Calcium,Aspartate, Dipotassium,Aspartate, Disodium,Aspartate, Magnesium,Aspartate, Monopotassium,Aspartate, Monosodium,Aspartate, Potassium,Aspartate, Sodium,L Aspartate,L Aspartic Acid
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
April 1996, Neuropediatrics,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
November 1994, Italian journal of neurological sciences,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
December 1988, Stroke,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
August 1992, Stroke,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
August 2001, Annals of neurology,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
January 2015, Clinical radiology,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
April 1995, Neuropediatrics,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
August 2007, Brain injury,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
January 2015, Frontiers in cardiovascular medicine,
G D Graham, and A M Blamire, and A M Howseman, and D L Rothman, and P B Fayad, and L M Brass, and O A Petroff, and R G Shulman, and J W Prichard
January 1997, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!